Hemogenyx Pharmaceuticals (HEMO) Stock Chart & Stock Price History GBX 184.50 +4.50 (+2.50%) As of 05/2/2025 12:20 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock Hemogenyx Pharmaceuticals Stock Price Performance 5 Day Performance+2.22%1 Month Performance+1.39%3 Month Performance-46.15%6 Month Performance+14,314.06%Year-To-Date Performance-54.10%1 Year Performance+11,689.14% Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address HEMO Stock Chart for Sunday, May, 4, 2025 HEMO Chart by TradingView Hemogenyx Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025GBX 178.88GBX 184.50+3.14%GBX 191.50GBX 180.5037,062 shs£6.58 million05/01/2025GBX 183GBX 178.88-2.25%GBX 182GBX 17816,465 shs£6.38 million04/30/2025GBX 180.50GBX 183+1.39%GBX 183GBX 180.509,078 shs£6.52 million04/29/2025GBX 185GBX 180.50-2.43%GBX 183GBX 180.5020,758 shs£6.43 million04/28/2025GBX 185GBX 185GBX 185GBX 180.157,472 shs£6.59 million04/25/2025GBX 182.48GBX 185+1.38%GBX 189.50GBX 180.5038,224 shs£6.59 million04/24/2025GBX 185.90GBX 182.48-1.84%GBX 187GBX 18061,461 shs£6.50 million04/23/2025GBX 185.25GBX 185.90+0.35%GBX 193.50GBX 18262,363 shs£6.63 million04/22/2025GBX 172.50GBX 185.25+7.39%GBX 194GBX 167.5071,207 shs£6.60 million04/21/2025GBX 172.50GBX 172.50GBX 172.50GBX 165.5041,412 shs£6.15 million Get the Latest News and Ratings for HEMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025GBX 172.50GBX 172.50GBX 172.50GBX 165.5041,412 shs£6.15 million04/17/2025GBX 171GBX 172.50+0.88%GBX 172.50GBX 165.5041,412 shs£6.15 million04/16/2025GBX 170.50GBX 171+0.29%GBX 171GBX 165.7523,526 shs£6.10 million04/15/2025GBX 168.70GBX 170.50+1.07%GBX 170.50GBX 16511,464 shs£6.08 million04/14/2025GBX 168.50GBX 168.70+0.12%GBX 173.22GBX 168.2015,254 shs£6.01 million04/11/2025GBX 171.75GBX 168.50-1.89%GBX 173.85GBX 165.5038,767 shs£6.01 million04/10/2025GBX 167.25GBX 171.75+2.69%GBX 173.75GBX 16717,117 shs£6.12 million04/09/2025GBX 172.75GBX 167.25-3.18%GBX 167.25GBX 16524,101 shs£5.96 million04/09/2025GBX 172.75GBX 167.25-3.18%GBX 167.25GBX 16524,101 shs£5.96 million04/08/2025GBX 174.50GBX 172.75-1.00%GBX 174.50GBX 165.5020,310 shs£6.16 million04/08/2025GBX 174.50GBX 172.75-1.00%GBX 174.50GBX 165.5020,310 shs£6.16 million04/07/2025GBX 181.98GBX 174.50-4.11%GBX 180.25GBX 165.5034,777 shs£6.22 million04/04/2025GBX 189GBX 181.98-3.72%GBX 190GBX 181.9810,123 shs£6.49 million04/03/2025GBX 194.36GBX 189-2.76%GBX 195GBX 1892,507 shs£6.74 million Related Companies Sareum Stock Price Chart OptiBiotix Health Stock Price Chart Poolbeg Pharma Stock Price Chart Arecor Therapeutics Stock Price Chart ImmuPharma Stock Price Chart Synairgen Stock Price Chart IXICO Stock Price Chart Oxford BioDynamics Stock Price Chart Aptamer Group Stock Price Chart Cizzle Biotechnology Stock Price Chart Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:HEMO) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemogenyx Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemogenyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HEMO Stock Free HEMO Stock Alerts